Wood E, Lim R, Kerr T Initiation of opiate addiction in a Canadian prison: a case report Harm Reduction Journal, 2006. PubMed


Lloyd-Smith E, Brodkin E, Wood E, Kerr T, Tyndall MW, Montaner JS, Hogg RS Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia AIDS, 2006. PubMed


Spittal PM, Hogg RS, Li K, Craib KJ, Recsky M, Johnston C, Montaner JS, Schechter MT, Wood E Drastic elevations in mortality among female injection drug users in a Canadian setting AIDS Care, 2006. PubMed


Kerr T, Stoltz J, Tyndall M, Li K, Zhang R, Montaner J, Wood E Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study British Medical Journal, 2006. PubMed


Shannon K, Ishida T, Morgan R, Bear A, Oleson M, Kerr T, Tyndall MW Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users Harm Reduction Journal, 2006. PubMed


Kuyper LM, Kerr T, Li K, Hogg RS, Tyndall MW, Montaner JS, Wood E Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs Substance Use & Misuse, 2006. PubMed


Miller CL, Kerr T, Frankish J, Spittal P, Li K, Schechter MT, Wood E Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies Substance Use & Misuse, 2006. PubMed


Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JS, Tyndall MW Prevalence and correlates of hepatitis C infection among users of North America’s first medically supervised safer injection facility Public Health, 2005. PubMed


Small W, Wood E, Jürgens R, Kerr T Injection drug use, HIV/AIDS and incarceration: evidence from the Vancouver Injection Drug Users Study HIV/AIDS Policy & Law Review, 2005. PubMed


O'Connell JM, Kerr T, Li K, Tyndall MW, Hogg RS, Montaner JS, Wood E Requiring help injecting independently predicts incident HIV infection among injection drug users Journal of Acquired Immune Deficiency Syndromes, 2005. PubMed


BC Centre on Substance Use

400-1045 Howe St, Vancouver, BC V6Z 2A9


E: [email protected] | T: (778) 945-7616 | F: (604) 428-5183

24/7 Addiction Clinician Support Line: (778) 945-7619

Online Addiction Medicine Diploma: [email protected].


website logos footer

Copyright © 2023, BC Centre on Substance Use